Yea, I’ve seen cashing out the principal+next investment and letting the rest ride.

Ah yea, biotech has been around for a while now and almost all best selling drugs are biotech drugs now a days.

Unsure if you’re genuine or trying to be edgy, but I’ll bite—-yes, most of them make significant profits currently.

Not op, but I’m in the field and can give you some things to read about:

- CAR-T

- CRISPR

- PRIME editing

- Base editing

- Modified mRNA

- PD-1 inhibitors

- On the cusp of personalized cancer vaccines

- ADCs

- Structure correctors

- Targeted protein degraders

- siRNAs

These have all really hit their stride in the past 15 years. Guess where all of them initially came from? Random ass government-funded academic research. Sure, you can split hairs with me on the 15 years and NIH/NSF etc funding, but it’s basically true. We are killing the golden goose…

This is a perfect analogy.

Source: Am structural biochemist